GenAI: The care plan for powering positive health outcomes
GenAI is positively disrupting industries around the world with greater productivity and impact on the bottom line. Healthcare and life sciences are no exception.
While the majority foresee a positive impact of GenAI in years to come, many organizations are struggling to optimize their GenAI investments. Here’s a preview of what more than 400 healthcare and life sciences executives have revealed:
- Only 54% currently classify their GenAI capability as high-performing.
- 51% have already assessed the GenAI opportunity to streamline patient experiences and 94% will have done so within the next year.
- Only 48% have assessed their data readiness (including data platforms and management) as a foundation for scalable, secure, trusted and responsible GenAI.
And though the research shows 81% of healthcare organizations say they have a well-defined GenAI strategy in place, only 40% of the C-suite agree that the strategy is strongly aligned to the business strategy.
What you’ll learn:
- How to establish governance and decision-making frameworks to increase trust
- How to accelerate GenAI implementations strategically to realize real healthcare value
- How to prepare and empower the workforce to succeed with GenAI